News-Medical.Net on MSN
New TOR inhibitor rapalink-1 prolongs chronological lifespan in fission yeast
Researchers from Queen Mary University of London's School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs ...
News-Medical.Net on MSN
Proton therapy and IMRT show similar outcomes in head and neck cancer trial
A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...
Microsoft Copilot introduces Agent Mode in Office apps, enabling smarter document creation, analysis, and collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results